Singapore-based healthcare investor HealthXCapital says it expects to close up to three more deals by 2020-end as it looks to capitalise on the flurry of opportunities in the healthtech sector amid the COVID-19 crisis.
“We were already looking at a high number of healthtech deals in Southeast Asia since 2018, but the pandemic has added fuel to the fire,” said HealthXCapital partner Seemant Jauhari.
